A case-control study was conducted in Sweden to investigate the association between malignant brain tumors and the use of mobile phones and cordless phones.
The results of this case-control study for meningioma are published in Carlberg et al (2013).
The unexposed group was defined as following: no use of mobile phone or cordless phone or less than 1 year between first use and year of diagnosis or cumulative use less than 39 hours.
Group | Description |
---|---|
Reference group 1 | unexposed |
Group 2 | analog mobile phone > 1 year latency period |
Group 3 | analog mobile phone > 1- to 5-year latency period |
Group 4 | analog mobile phone > 5- to 10-year latency period |
Group 5 | analog mobile phone > 10- to 15-year latency period |
Group 6 | analog mobile phone > 15- to 20-year latency period |
Group 7 | analog mobile phone > 20- to 25 -year latency period |
Group 8 | analog mobile phone > 25-year latency period |
Group 9 | digital (2G) mobile phone > 1 year latency period |
Group 10 | digital (2G) mobile phone > 1- to 5-year latency period |
Group 11 | digital (2G) mobile phone > 5- to 10-year latency period |
Group 12 | digital (2G) mobile phone > 10- to 15-year latency period |
Group 13 | digital (2G) mobile phone > 15- to 20-year latency period |
Group 14 | digital (2G) mobile phone > 20- to 25 -year latency period |
Group 15 | digital (2G) mobile phone > 25-year latency period |
Group 16 | digital (3G) mobile phone > 1 year latency period |
Group 17 | digital (3G) mobile phone > 1- to 5-year latency period |
Group 18 | digital (3G) mobile phone > 5- to 10-year latency period |
Group 19 | digital (3G) mobile phone > 10- to 15-year latency period |
Group 20 | digital (3G) mobile phone > 15- to 20-year latency period |
Group 21 | digital (3G) mobile phone > 20- to 25 -year latency period |
Group 22 | digital (3G) mobile phone > 25-year latency period |
Group 23 | mobile phone > 1 year latency period |
Group 24 | mobile phone > 1- to 5-year latency period |
Group 25 | mobile phone > 5- to 10-year latency period |
Group 26 | mobile phone > 10- to 15-year latency period |
Group 27 | mobile phone > 15- to 20-year latency period |
Group 28 | mobile phone > 20- to 25 -year latency period |
Group 29 | mobile phone > 25-year latency period |
Group 30 | cordless phone > 1 year latency period |
Group 31 | cordless phone > 1- to 5-year latency period |
Group 32 | cordless phone > 5- to 10-year latency period |
Group 33 | cordless phone > 10- to 15-year latency period |
Group 34 | cordless phone > 15- to 20-year latency period |
Group 35 | cordless phone > 20- to 25 -year latency period |
Group 36 | cordless phone > 25-year latency period |
Group 37 | digital phone (2G, 3G and/or cordless phone) > 1 year latency period |
Group 38 | digital phone (2G, 3G and/or cordless phone) > 1- to 5-year latency period |
Group 39 | digital phone (2G, 3G and/or cordless phone) > 5- to 10-year latency period |
Group 40 | digital phone (2G, 3G and/or cordless phone) > 10- to 15-year latency period |
Group 41 | digital phone (2G, 3G and/or cordless phone) > 15- to 20-year latency period |
Group 42 | digital phone (2G, 3G and/or cordless phone) > 20- to 25 -year latency period |
Group 43 | digital phone (2G, 3G and/or cordless phone) > 25-year latency period |
Group 44 | wireless phone > 1 year latency period |
Group 45 | wireless phone > 1- to 5-year latency period |
Group 46 | wireless phone > 5- to 10-year latency period |
Group 47 | wireless phone > 10- to 15-year latency period |
Group 48 | wireless phone > 15- to 20-year latency period |
Group 49 | wireless phone > 20- to 25 -year latency period |
Group 50 | wireless phone > 25-year latency period |
Cases | Controls | |
---|---|---|
Eligible | 1,334 | 1,601 |
Contacted | 683 | - |
Participants | 593 | 1,368 |
Participation rate | 87 % | 85 % |
An increased risk for malignant brain tumors was observed for mobile phone use of the analogue type (OR 1.8, CI 1.04-3.3), increasing with >25 years of latency (OR 3.3, CI 1.6-6.9). Increased risks were found for digital 2G mobile phone use (OR 1.6, CI 0.996-2.7), increasing with latency >15-20 years (OR 2.1, CI 1.2-3.6) and for cordless phone use (OR 1.7, CI 1.1-2.9; latency >15-20 years: OR 2.1, CI 1.2-3.8). Use of digital mobile phones and cordless phones gave increased risk with latency >1-5 years, then a lower risk in the following latency groups, but again increasing risk with latency >15-20 years. Ipsilateral use resulted in a higher risk than contralateral mobile phone and cordless phone use. Higher odds ratios were calculated for brain tumors in the temporal and overlapping lobes.
The authors concluded that this study confirmed previous results of an association between malignant brain tumors and the use of mobile phones and cordless phones. These findings provide support for the hypothesis that RF-EMFs play a role both in the initiation and promotion stages of carcinogenesis.
This website uses cookies to provide you the best browsing experience. By continuing to use this website you accept our use of cookies.